A prospective multicenter phase II study evaluating multimodality treatment of patients with peritoneal carcinomatosis arising from appendiceal and colorectal cancer: the COMBATAC trial

<p>Abstract</p> <p>Background</p> <p>Peritoneal carcinomatosis is regarded as a common sign of advanced tumor stage, tumor progression or local recurrence of appendiceal and colorectal cancer and is generally associated with poor prognosis. Although survival of patients...

Celý popis

Uloženo v:
Podrobná bibliografie
Hlavní autoři: Glockzin Gabriel, Rochon Justine, Arnold Dirk, Lang Sven A, Klebl Frank, Zeman Florian, Koller Michael, Schlitt Hans J, Piso Pompiliu
Médium: Artigo
Jazyk:Inglês
Vydáno: BMC 2013-02-01
Edice:BMC Cancer
Témata:
Cytoreductive surgery
HIPEC
Perioperative chemotherapy
Cetuximab
Colorectal cancer
Peritoneal carcinomatosis
On-line přístup:http://www.biomedcentral.com/1471-2407/13/67
Tagy: Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!

Podobné jednotky